famotidine has been researched along with Acute Disease in 29 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the efficacy and safety of hydrotalcite with the H2 receptor antagonist famotidine and placebo in the on-demand treatment of acute heartburn under daily practice conditions." | 9.12 | On-demand treatment of acute heartburn with the antacid hydrotalcite compared with famotidine and placebo: randomized double-blind cross-over study. ( Caspary, WF; Holtmann, G; Holtmeier, W; Weingärtner, U, 2007) |
| "A multicentric double-blind trial comparing 600 mg/d of Zinc Acexamate (ACZ) and 40 mg/d of Famotidine (FMT) in the short term treatment of acute duodenal ulcer included 199 patients, diagnosed by endoscopy." | 9.08 | [A multicenter clinical trial. Zinc acexamate versus famotidine in the treatment of acute duodenal ulcer. Study Group of Zinc acexamate (new UP doses)]. ( Arenas, JI; Belda, O; de la Santa, Jw; Diago, A; Domínguez, A; Fernández, C; García-Plaza, A; Martín, L; Pallarés, A; Rodrigo, L, 1996) |
| "The efficacy of famotidine, a potent new long-acting H2 receptor antagonist, was compared with cimetidine in 78 patients with endoscopically proven acute duodenal ulcers." | 9.06 | Famotidine versus cimetidine in the treatment of acute duodenal ulcer. Double-blind, randomized clinical trial comparing nocturnal administration of 40 mg famotidine to 800 mg cimetidine. ( Fölsch, UR; Hartmann, H, 1988) |
| "Famotidine, a new H2 antagonist in a dose of 40 mg qhs was tried in a clinical trial for the treatment of duodenal ulcer in 25 patients and compared with other H2 antagonists." | 9.06 | Treatment of acute duodenal ulcers with famotidine and its comparison with other H2 blockers. ( Akhtar, MA; Khan, MA; Rashid, P, 1990) |
| "This multicentric, double-blind and prospective study, which involved 41 French Gastroenterology Units, was designed to evaluate the efficacy and safety of famotidine, 40 mg at bedtime, compared to single dose ranitidine, 300 mg, in promoting the healing of duodenal ulcer." | 9.06 | [Comparative efficacy of famotidine and ranitidine in the treatment of acute-phase duodenal ulcer. A French comparative therapeutic trial]. ( Delvaux, M; Hagège, CG; Ribet, A, 1989) |
| "Three hundred thirty-six patients with endoscopically diagnosed benign gastric ulcers, randomly allocated to treatment with 40 mg famotidine at night or placebo, were evaluated in a double-blind multicenter trial conducted in 14 countries worldwide." | 9.06 | Famotidine once-a-day in the therapy of acute, benign gastric ulcer: a worldwide experience. ( Dammann, HG; Müller, P; Simon, B, 1987) |
| "The new H2 receptor antagonist, famotidine, has been tested in open and double-blind studies in over 2,000 acute duodenal or gastric ulcer patients as well as in the maintenance of chronic duodenal ulcer patients." | 9.05 | Famotidine in the treatment of gastric and duodenal ulceration: overview of clinical experience. ( Bianchi Porro, G, 1985) |
| "The aim was to compare the clinical efficacy of lansoprazole with the efficacies of ranitidine and famotidine in order to rank this drug in the hierarchy of duodenal ulcer treatments." | 8.79 | Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer. ( Agostini, H; Lemaire, M; Poynard, T, 1995) |
| "Acute intermittent porphyria (AIP) is a rare metabolic disorder of heme biosynthesis characterized by enzymatic defect of porphobiligen desaminase with accumulation and increased excretion of porphyrins and their precursors." | 7.75 | [Neurological complications of acute intermittent porphyria precipitated by porphyrinogenic drugs and efficiency of heme-arginate treatment]. ( Akopova-Larbi, R; Ben Youssef, TI; Gargouri, A; Gouider, R; Gouider-Khouja, N; Kraoua, I, 2009) |
| "Famotidine was found to reduce pruritus associated with acute urticaria, intensity of urticaria, and body surface area affected by urticaria without causing sedation." | 6.69 | Famotidine in the treatment of acute urticaria. ( Harter, PM; Watson, NT; Weiss, EL, 2000) |
| " In view of possible increased patient compliance with a simplified dosage regimen, famotidine 40 mg h." | 6.66 | Review of an extensive worldwide study of a new H2-receptor antagonist, famotidine, as compared to ranitidine in the treatment of acute duodenal ulcer. ( Bianchi Porro, G; Cook, T; Dicenta, C; Humphries, TJ, 1987) |
| "Gastric ulcer is a multifaceted process including acid secretion, reactive oxygen species generation, prostaglandin inhibition, and extracellular matrix (ECM) degradation." | 5.34 | Novel role of famotidine in downregulation of matrix metalloproteinase-9 during protection of ethanol-induced acute gastric ulcer. ( Ganguly, K; Kundu, P; Mishra, A; Pradeepkumar Singh, L; Swarnakar, S, 2007) |
| "In treatment of severe acute pancreatitis of paramount importance are the terms of the beginning of antisecretory therapy, the optimum term being the first day of the disease." | 5.31 | [Comparative characteristics of octreotide and famotidine in the treatment of acute pancreatitis]. ( Bagnenko, SF; Gol'tsov, VR; Nazarov, VE; Rukhliada, NV; Tolstoĭ, AD, 2002) |
| "The patient was diagnosed with acute tubulointerstitial nephritis caused by cefdinir." | 5.31 | Successful steroid therapy for cefdinir-induced acute tubulointerstitial nephritis with progressive renal failure. ( Fujiwara, T; Hiramori, K; Kawamura, M; Kimura, Y; Maesawa, C; Owada, M, 2001) |
| "To compare the efficacy and safety of hydrotalcite with the H2 receptor antagonist famotidine and placebo in the on-demand treatment of acute heartburn under daily practice conditions." | 5.12 | On-demand treatment of acute heartburn with the antacid hydrotalcite compared with famotidine and placebo: randomized double-blind cross-over study. ( Caspary, WF; Holtmann, G; Holtmeier, W; Weingärtner, U, 2007) |
| "The aim of the study was to assess effects of H2-blocker of the IIId generation famotidine (quamatel) on the progression of acute and chronic pancreatitis and intensity of pain in patients with pancreatitis." | 5.09 | [Quamatel in the treatment of acute and chronic pancreatitis]. ( Belousova, EA; Dolgova, MB; Filizhanko, VN; Lovakov, AI; Nikulin, IV; Shemeneva, EG; Zlatkin, AR, 2000) |
| "A multicentric double-blind trial comparing 600 mg/d of Zinc Acexamate (ACZ) and 40 mg/d of Famotidine (FMT) in the short term treatment of acute duodenal ulcer included 199 patients, diagnosed by endoscopy." | 5.08 | [A multicenter clinical trial. Zinc acexamate versus famotidine in the treatment of acute duodenal ulcer. Study Group of Zinc acexamate (new UP doses)]. ( Arenas, JI; Belda, O; de la Santa, Jw; Diago, A; Domínguez, A; Fernández, C; García-Plaza, A; Martín, L; Pallarés, A; Rodrigo, L, 1996) |
| "This multicentric, double-blind and prospective study, which involved 41 French Gastroenterology Units, was designed to evaluate the efficacy and safety of famotidine, 40 mg at bedtime, compared to single dose ranitidine, 300 mg, in promoting the healing of duodenal ulcer." | 5.06 | [Comparative efficacy of famotidine and ranitidine in the treatment of acute-phase duodenal ulcer. A French comparative therapeutic trial]. ( Delvaux, M; Hagège, CG; Ribet, A, 1989) |
| "Famotidine, a new H2 antagonist in a dose of 40 mg qhs was tried in a clinical trial for the treatment of duodenal ulcer in 25 patients and compared with other H2 antagonists." | 5.06 | Treatment of acute duodenal ulcers with famotidine and its comparison with other H2 blockers. ( Akhtar, MA; Khan, MA; Rashid, P, 1990) |
| "Three hundred thirty-six patients with endoscopically diagnosed benign gastric ulcers, randomly allocated to treatment with 40 mg famotidine at night or placebo, were evaluated in a double-blind multicenter trial conducted in 14 countries worldwide." | 5.06 | Famotidine once-a-day in the therapy of acute, benign gastric ulcer: a worldwide experience. ( Dammann, HG; Müller, P; Simon, B, 1987) |
| "The efficacy of famotidine, a potent new long-acting H2 receptor antagonist, was compared with cimetidine in 78 patients with endoscopically proven acute duodenal ulcers." | 5.06 | Famotidine versus cimetidine in the treatment of acute duodenal ulcer. Double-blind, randomized clinical trial comparing nocturnal administration of 40 mg famotidine to 800 mg cimetidine. ( Fölsch, UR; Hartmann, H, 1988) |
| "The new H2 receptor antagonist, famotidine, has been tested in open and double-blind studies in over 2,000 acute duodenal or gastric ulcer patients as well as in the maintenance of chronic duodenal ulcer patients." | 5.05 | Famotidine in the treatment of gastric and duodenal ulceration: overview of clinical experience. ( Bianchi Porro, G, 1985) |
| "The aim was to compare the clinical efficacy of lansoprazole with the efficacies of ranitidine and famotidine in order to rank this drug in the hierarchy of duodenal ulcer treatments." | 4.79 | Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer. ( Agostini, H; Lemaire, M; Poynard, T, 1995) |
| "Acute intermittent porphyria (AIP) is a rare metabolic disorder of heme biosynthesis characterized by enzymatic defect of porphobiligen desaminase with accumulation and increased excretion of porphyrins and their precursors." | 3.75 | [Neurological complications of acute intermittent porphyria precipitated by porphyrinogenic drugs and efficiency of heme-arginate treatment]. ( Akopova-Larbi, R; Ben Youssef, TI; Gargouri, A; Gouider, R; Gouider-Khouja, N; Kraoua, I, 2009) |
| "Famotidine was found to reduce pruritus associated with acute urticaria, intensity of urticaria, and body surface area affected by urticaria without causing sedation." | 2.69 | Famotidine in the treatment of acute urticaria. ( Harter, PM; Watson, NT; Weiss, EL, 2000) |
| " In view of possible increased patient compliance with a simplified dosage regimen, famotidine 40 mg h." | 2.66 | Review of an extensive worldwide study of a new H2-receptor antagonist, famotidine, as compared to ranitidine in the treatment of acute duodenal ulcer. ( Bianchi Porro, G; Cook, T; Dicenta, C; Humphries, TJ, 1987) |
| " The aim of this study was to investigate the pharmacokinetic alteration of cationic drugs and the expression of tubular organic cation transporters, rOCT1, rOCT2, and rMATE1, in ischemia/reperfusion (I/R)-induced AKI rats." | 1.35 | Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injury. ( Hamada, A; Inui, K; Matsuzaki, T; Morisaki, T; Nonoguchi, H; Saito, H; Sato, D; Sugimoto, W; Terada, T; Tomita, K; Yokoo, K, 2008) |
| "Gastric ulcer is a multifaceted process including acid secretion, reactive oxygen species generation, prostaglandin inhibition, and extracellular matrix (ECM) degradation." | 1.34 | Novel role of famotidine in downregulation of matrix metalloproteinase-9 during protection of ethanol-induced acute gastric ulcer. ( Ganguly, K; Kundu, P; Mishra, A; Pradeepkumar Singh, L; Swarnakar, S, 2007) |
| "Oesophagitis was induced by pyloric ligation in wild-type and VR-1 deficient mice." | 1.33 | Attenuation of acid induced oesophagitis in VR-1 deficient mice. ( de la Fuente, SG; Fujino, K; Mantyh, CR; Takahashi, T; Takami, Y, 2006) |
| "We report a case of acute pancreatitis, which occurred after delivery in a woman who had an uneventful course of pregnancy and parturition." | 1.32 | Acute pancreatitis occurring in the early postpartum period: a case report. ( Chaen, H; Eguchi, F; Fukami, T; Imura, H; Sudou, K, 2003) |
| "The patient was diagnosed with acute tubulointerstitial nephritis caused by cefdinir." | 1.31 | Successful steroid therapy for cefdinir-induced acute tubulointerstitial nephritis with progressive renal failure. ( Fujiwara, T; Hiramori, K; Kawamura, M; Kimura, Y; Maesawa, C; Owada, M, 2001) |
| "In treatment of severe acute pancreatitis of paramount importance are the terms of the beginning of antisecretory therapy, the optimum term being the first day of the disease." | 1.31 | [Comparative characteristics of octreotide and famotidine in the treatment of acute pancreatitis]. ( Bagnenko, SF; Gol'tsov, VR; Nazarov, VE; Rukhliada, NV; Tolstoĭ, AD, 2002) |
| "Lansoprazole was more potent than omeprazole, famotidine and ranitidine in inhibiting gastric mucosal lesions and hemorrhagic shock- or stress-induced bleeding." | 1.29 | [Effects of intravenous lansoprazole on acute gastric mucosal lesions and acid secretion]. ( Asano, S; Inada, I; Inatomi, N; Murakami, I; Satoh, H, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (20.69) | 18.7374 |
| 1990's | 7 (24.14) | 18.2507 |
| 2000's | 12 (41.38) | 29.6817 |
| 2010's | 4 (13.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsueda, K | 1 |
| Toyokawa, T | 1 |
| Sakata, M | 1 |
| Fujita, I | 1 |
| Horii, J | 1 |
| Abe, Y | 1 |
| Araki, T | 1 |
| Kormos, W | 1 |
| Nichitaĭlo, ME | 1 |
| Akopova-Larbi, R | 1 |
| Ben Youssef, TI | 1 |
| Gargouri, A | 1 |
| Kraoua, I | 1 |
| Gouider, R | 1 |
| Gouider-Khouja, N | 1 |
| Trepanier, L | 1 |
| Bagnenko, SF | 1 |
| Rukhliada, NV | 1 |
| Tolstoĭ, AD | 1 |
| Gol'tsov, VR | 1 |
| Nazarov, VE | 1 |
| Fukami, T | 1 |
| Chaen, H | 1 |
| Imura, H | 1 |
| Sudou, K | 1 |
| Eguchi, F | 1 |
| Fujino, K | 1 |
| de la Fuente, SG | 1 |
| Takami, Y | 1 |
| Takahashi, T | 1 |
| Mantyh, CR | 1 |
| Gostishchev, VK | 1 |
| Evseev, MA | 1 |
| Holtmeier, W | 1 |
| Holtmann, G | 1 |
| Caspary, WF | 1 |
| Weingärtner, U | 1 |
| Pradeepkumar Singh, L | 1 |
| Kundu, P | 1 |
| Ganguly, K | 1 |
| Mishra, A | 1 |
| Swarnakar, S | 1 |
| Matsuzaki, T | 1 |
| Morisaki, T | 1 |
| Sugimoto, W | 1 |
| Yokoo, K | 1 |
| Sato, D | 1 |
| Nonoguchi, H | 1 |
| Tomita, K | 1 |
| Terada, T | 1 |
| Inui, K | 1 |
| Hamada, A | 1 |
| Saito, H | 1 |
| Vargas, V | 1 |
| Castro, J | 1 |
| del Solar, F | 1 |
| Sanhueza, H | 1 |
| Aguila, R | 1 |
| Luppi, M | 1 |
| Fernández, D | 1 |
| Rojas, M | 1 |
| Poynard, T | 1 |
| Lemaire, M | 1 |
| Agostini, H | 1 |
| García-Plaza, A | 1 |
| Arenas, JI | 1 |
| Belda, O | 1 |
| Diago, A | 1 |
| Domínguez, A | 1 |
| Fernández, C | 1 |
| Martín, L | 1 |
| Pallarés, A | 1 |
| Rodrigo, L | 1 |
| de la Santa, Jw | 1 |
| Inatomi, N | 1 |
| Murakami, I | 1 |
| Asano, S | 1 |
| Inada, I | 1 |
| Satoh, H | 1 |
| Watson, NT | 1 |
| Weiss, EL | 1 |
| Harter, PM | 1 |
| Belousova, EA | 1 |
| Zlatkin, AR | 1 |
| Nikulin, IV | 1 |
| Lovakov, AI | 1 |
| Filizhanko, VN | 1 |
| Shemeneva, EG | 1 |
| Dolgova, MB | 1 |
| Jiménez-Sáenz, M | 1 |
| Argüelles-Arias, F | 1 |
| Herrerías-Gutiérrez, JM | 1 |
| Durán-Quintana, JA | 1 |
| Kimura, Y | 1 |
| Kawamura, M | 1 |
| Owada, M | 1 |
| Fujiwara, T | 1 |
| Maesawa, C | 1 |
| Hiramori, K | 1 |
| Bianchi Porro, G | 3 |
| Lazzaroni, M | 1 |
| Barbara, L | 1 |
| Corinaldesi, R | 1 |
| Blasi, A | 1 |
| Mangiameli, A | 1 |
| Capurso, L | 1 |
| Koch, M | 1 |
| Cheli, R | 1 |
| Bovero, E | 1 |
| Brouard, A | 1 |
| Conort, O | 1 |
| Terrier, JL | 1 |
| Akhtar, MA | 1 |
| Rashid, P | 1 |
| Khan, MA | 1 |
| Delvaux, M | 1 |
| Hagège, CG | 1 |
| Ribet, A | 1 |
| Dicenta, C | 1 |
| Cook, T | 1 |
| Humphries, TJ | 1 |
| Simon, B | 1 |
| Müller, P | 1 |
| Dammann, HG | 1 |
| Hartmann, H | 1 |
| Fölsch, UR | 1 |
| Kimmig, JM | 1 |
2 reviews available for famotidine and Acute Disease
| Article | Year |
|---|---|
Acute vomiting in cats: rational treatment selection.
Topics: Acute Disease; Animals; Antiemetics; Cat Diseases; Cats; Chlorpromazine; Diarrhea; Famotidine; Indol | 2010 |
Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Anti-Ulcer Agents; Duodenal Ulcer; Famotidin | 1995 |
13 trials available for famotidine and Acute Disease
| Article | Year |
|---|---|
On-demand treatment of acute heartburn with the antacid hydrotalcite compared with famotidine and placebo: randomized double-blind cross-over study.
Topics: Acute Disease; Adolescent; Adult; Aged; Aluminum Hydroxide; Antacids; Cross-Over Studies; Double-Bli | 2007 |
[Comparative study of famotidine vs ranitidine in critically ill patients in mechanical ventilation].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Critical Care; Double-Blind Method; Famotidine; Femal | 1993 |
[A multicenter clinical trial. Zinc acexamate versus famotidine in the treatment of acute duodenal ulcer. Study Group of Zinc acexamate (new UP doses)].
Topics: Acute Disease; Adult; Aged; Aminocaproates; Aminocaproic Acid; Anti-Ulcer Agents; Double-Blind Metho | 1996 |
Famotidine in the treatment of acute urticaria.
Topics: Acute Disease; Adolescent; Adult; Antipruritics; Diphenhydramine; Double-Blind Method; Famotidine; F | 2000 |
[Quamatel in the treatment of acute and chronic pancreatitis].
Topics: Acute Disease; Adult; Chronic Disease; Disease Progression; Famotidine; Female; Histamine H2 Antagon | 2000 |
Famotidine vs ranitidine h.s. in acute duodenal ulcer. A multicentre endoscopic trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Double-Blind Method; Duodenal Ulcer; Endoscopy, Gastrointest | 1991 |
Treatment of acute duodenal ulcers with famotidine and its comparison with other H2 blockers.
Topics: Acute Disease; Adolescent; Adult; Aged; Duodenal Ulcer; Famotidine; Female; Histamine H2 Antagonists | 1990 |
[Comparative efficacy of famotidine and ranitidine in the treatment of acute-phase duodenal ulcer. A French comparative therapeutic trial].
Topics: Acute Disease; Adolescent; Adult; Aged; Cicatrix; Clinical Trials as Topic; Double-Blind Method; Dru | 1989 |
Famotidine in the treatment of gastric and duodenal ulceration: overview of clinical experience.
Topics: Acute Disease; Chronic Disease; Cimetidine; Circadian Rhythm; Clinical Trials as Topic; Double-Blind | 1985 |
Review of an extensive worldwide study of a new H2-receptor antagonist, famotidine, as compared to ranitidine in the treatment of acute duodenal ulcer.
Topics: Acute Disease; Adult; Antacids; Duodenal Ulcer; Famotidine; Female; Histamine H2 Antagonists; Humans | 1987 |
Famotidine once-a-day in the therapy of acute, benign gastric ulcer: a worldwide experience.
Topics: Acute Disease; Adult; Antacids; Double-Blind Method; Drug Administration Schedule; Famotidine; Hista | 1987 |
Famotidine versus cimetidine in the treatment of acute duodenal ulcer. Double-blind, randomized clinical trial comparing nocturnal administration of 40 mg famotidine to 800 mg cimetidine.
Topics: Acute Disease; Adult; Aged; Anti-Ulcer Agents; Cimetidine; Clinical Trials as Topic; Double-Blind Me | 1988 |
[Acute therapy of duodenal ulcer. Comparison of famotidine and ranitidine in a single evening dose].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Ulcer Agents; Clinical Trials as Topic; Double-Blind Me | 1987 |
14 other studies available for famotidine and Acute Disease
| Article | Year |
|---|---|
Hemorrhagic Stress-induced Gastric Ulcer in a Healthy Toddler.
Topics: Acute Disease; Endoscopy; Famotidine; Female; Gastrointestinal Hemorrhage; Humans; Infant; Peptic Ul | 2018 |
On call. I have heartburn a few times a month. My doctor suggested I use a generic H₂blocker like famotidine or ranitidine. Is this better than an antacid?
Topics: Acute Disease; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drugs, Generic; Famotidine; Hear | 2014 |
[Prophylaxis of an acute postoperative pancreatitis and the stress ulcers occurrence after operations, performed on organs of hepatopancreatoduodenal zone, using miniinvasive and open access].
Topics: Acute Disease; Drug Administration Schedule; Drug Dosage Calculations; Duodenal Ulcer; Endoscopy, Ga | 2014 |
[Neurological complications of acute intermittent porphyria precipitated by porphyrinogenic drugs and efficiency of heme-arginate treatment].
Topics: Acute Disease; Adolescent; Arginine; Electromyography; Famotidine; Female; Heme; Heme Oxygenase (Dec | 2009 |
[Comparative characteristics of octreotide and famotidine in the treatment of acute pancreatitis].
Topics: Acute Disease; Famotidine; Gastrointestinal Agents; Histamine H2 Antagonists; Humans; Octreotide; Pa | 2002 |
Acute pancreatitis occurring in the early postpartum period: a case report.
Topics: Abdominal Pain; Acute Disease; Adolescent; Back Pain; Famotidine; Female; Gabexate; Histamine H2 Ant | 2003 |
Attenuation of acid induced oesophagitis in VR-1 deficient mice.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Capsaicin; Endocytosis; Esophagitis; Famotidine; Hydrogen | 2006 |
[Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].
Topics: Acute Disease; Anti-Ulcer Agents; Famotidine; Gastrointestinal Agents; Histamine H2 Antagonists; Hum | 2005 |
Novel role of famotidine in downregulation of matrix metalloproteinase-9 during protection of ethanol-induced acute gastric ulcer.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Cytokines; Disease Models, Animal; Ethanol; Famotidine; G | 2007 |
Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injury.
Topics: Acute Disease; Animals; Antiporters; Down-Regulation; Famotidine; Kidney; Male; Organic Cation Trans | 2008 |
[Effects of intravenous lansoprazole on acute gastric mucosal lesions and acid secretion].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Animals; Anti-Ulcer Agents; Famotidine; Gast | 1996 |
Acute cholestatic hepatitis in a child treated with famotidine.
Topics: Acute Disease; Adolescent; Chemical and Drug Induced Liver Injury; Cholestasis; Famotidine; Histamin | 2000 |
Successful steroid therapy for cefdinir-induced acute tubulointerstitial nephritis with progressive renal failure.
Topics: Acute Disease; Acute Kidney Injury; Anti-Infective Agents; Anti-Inflammatory Agents; Biopsy; Bronchi | 2001 |
H2-receptor antagonists and acute intermittent porphyria.
Topics: Acute Disease; Cimetidine; Drug Evaluation; Famotidine; Humans; Porphyrias; Ranitidine; Skin Disease | 1991 |